Revisión

Long-term evolution of childhood epilepsy treated with vigabatrin, outside clinical trials

C. Garaizar, M.J. Martínez-González, M.A. Fernández-Cuesta, J.M. Prats-Viñas DOI: https://doi.org/10.33588/rn.2903.99069

OPEN ACCESS

Volumen 29 | Number 03 | Nº of views of the article 5.634 | Nº of PDF downloads 202 | Article publication date 01/08/1999

Download PDF Castellano Citation Search in PubMed

Share in:

Go to another issue

ABSTRACT

INTRODUCTION Experimental conditions are not mirrored by clinical practice. OBJECTIVE. To study the efficacy of vigabatrin in the usual conditions of everyday clinical practice.

PATIENTS AND METHODS Retrospective review of all epileptic patients treated with vigabatrin in a neuropediatric outpatient clinic. Outcome measures: a) Persistent seizure frequency reduction ³50%, and total control of seizures. Potential predictors of response were studied by logistic regression. b) Duration of VGB therapy, studied by the Kaplan-Meier method and its associated log-rank test.

RESULTS 113 patients with: partial symptomatic epilepsy (38%), partial cryptogenic (25.6%), partial idiopathic (6%), West syndrome (14%), Lennox-Gastaut syndrome (6%), other syndromes (9.7%). Reduction of seizure frequency was attained by 60% of patients at 3 months, sustained during 12 months by 40%, and during 5 years by 14%. Total control of seizures was present in 33% of patients at 3 months, persisted 12 months in 18% and 5 years in 2%. Independent predictors of a poor outcome were generalized seizures (except infantile spasms) and cerebral palsy, among others. The probability of continuing vigabatrin (VGB) therapy was 78% at 6 months, 55% at 2 years and 32% at 5 years. Duration of therapy was modified by early therapeutic response and antecedent of status epilepticus, among others. Adverse events were recorded in 18.5%. Visual fields were not studied in these series.

CONCLUSIONS For the time being, VGB-treated patients belong to the difficult-to-treat group. Percentages of responders depend upon duration of follow-up KeywordsInfantile spasms Lennox-Gastaut syndrome Long-term follow-up Refractory childhood epilepsy Vigabatrin CategoriesEpilepsias y síndromes epilépticos

FULL TEXT (solo disponible en lengua castellana / Only available in Spanish)

Acceso directo al último número

Último Podcast

Revisión

Long-term evolution of childhood epilepsy treated with vigabatrin, outside clinical trials